Coronado Biosciences Inc Revenue Growth Rates (CNDO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Coronado Biosciences Inc  (CNDO)
 

CNDO's Revenue Growth by Quarter and Year

Coronado Biosciences Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CNDO Revenue (in millions $) FY 2014 FY 2013 FY 2012 FY 2011
4th Quarter December 0.00
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 0.00





CNDO Revenue fourth quarter 2014 Y/Y Growth Comment
Coronado Biosciences Inc in the fourth quarter 2014 recorded of $ 0.00 millions.

According to the results reported in the fourth quarter 2014, Coronado Biosciences Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Coronado Biosciences Inc' s Revenue no change of 0% ranks overall at the positon no. in the fourth quarter 2014.


CNDO Revenue ( Y/Y Growth %) 2014
 2013 2012 2011
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Coronado Biosciences Inc's fourth quarter 2014 Revenue $ 0.00 millions CNDO's Income Statement
Coronado Biosciences Inc's fourth quarter 2013 Revenue $ 0.00 millions Quarterly CNDO's Income Statement


CNDO Revenue (Quarter on Quarter Growth %)

 2014
 2013 2012 2011
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Back to CNDO Growth rate Comparisons >> Back to CNDO Growth rate Comparisons >>


Revenue fourth quarter 2014 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue fourth quarter 2014 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2011, 2012, 2013, 2014

Coronado Biosciences Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CNDO's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CNDO's IV. Quarter Q/Q Revenue Comment


Coronado Biosciences Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2014)		 12 Months Ending
(Dec 31 2013)		 12 Months Ending
 12 Months Ending
 12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Dec 31 2014 period, Coronado Biosciences Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Coronado Biosciences Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Dec 31 2014 period, Coronado Biosciences Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Coronado Biosciences Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CNDO's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Dec 31 2014 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2014
Yunhong Green Cti Ltd -0.14%$ -0.137 millions
Orasure Technologies Inc-0.30%$ -0.302 millions
Lineage Cell Therapeutics Inc -0.33%$ -0.329 millions
Veru Inc -0.46%$ -0.463 millions
Durect Corp-0.47%$ -0.466 millions
Lifemd Inc -0.55%$ -0.546 millions
Johnson and Johnson-0.55%$ -0.550 millions
Idexx Laboratories Inc-0.60%$ -0.597 millions
Cytosorbents Corporation-0.63%$ -0.626 millions
Bio rad Laboratories Inc -0.73%$ -0.730 millions
Select Medical Holdings Corp-1.39%$ -1.387 millions
Zimmer Biomet Holdings Inc -1.43%$ -1.435 millions
Aspira Women s Health inc -1.69%$ -1.692 millions
Perspective Therapeutics Inc -1.83%$ -1.826 millions
Remedent Inc -1.95%$ -1.951 millions
Cas Medical Systems Inc-1.96%$ -1.958 millions
Sonoma Pharmaceuticals Inc -2.28%$ -2.278 millions
Inergetics Inc-2.28%$ -2.279 millions
Delcath Systems Inc -2.35%$ -2.349 millions
Pra Health Sciences Inc -2.44%$ -2.440 millions
Magellan Health inc -2.55%$ -2.554 millions
Fonar Corporation-2.94%$ -2.936 millions
Precision Optics Corporation Inc -3.09%$ -3.093 millions
Scientific Industries Inc -3.24%$ -3.244 millions
Pfizer Inc-3.25%$ -3.245 millions
Invacare Holdings Corporation-3.82%$ -3.823 millions
Encision Inc -3.94%$ -3.944 millions
Bristol myers Squibb Company-4.12%$ -4.121 millions
Conmed Corporation-4.15%$ -4.148 millions
Haemonetics Corporation-4.25%$ -4.251 millions


About Coronado Biosciences Inc Revenue Growth Rates (CNDO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.